- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06369987
Visual Performance of Dailies Total1 Multifocal and Acuvue Oasys Max 1-Day Multifocal in Presbyopic Lens Wearers (GIRAFFE)
December 4, 2024 updated by: University of Waterloo
The purpose of this study is to measure the logMAR visual acuity when presbyopic soft lens wearers are fit with Dailies Total1 Multifocal and ACUVUE OASYS MAX 1-DAY Multifocal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Centre for Ocular Research & Education (CORE)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Are at least 42 years of age and has full legal capacity to volunteer;
- Have signed an information consent letter;
- Are willing and able to follow instructions and maintain the appointment schedule;
- Habitually wears soft contact lenses for the past 3 months (minimum);
- Are presbyopic and require a reading addition of at least +0.75D and no more than +1.75D;
- Can be refracted and achieve monocular spectacle distance vision of at least 20/25 Snellen (or +0.10logMAR) visual acuity;
- Have contact lens power requirements that fall within the available study lens parameters (distance sphere: +6D to -9D; near addition as per each lens design);
- Can be fit with the initial fitting guidelines provided by the lens manufacturer and use either Low or Medium Add (same add in both eyes).
Exclusion Criteria:
- Are a current habitual wearer of Dailies Total1 Multifocal or ACUVUE OASYS MAX 1-DAY Multifocal;
- Has refractive astigmatism higher than -0.75DC in either eye;
- Are participating in any concurrent clinical or research study involving intervention or invasive ocular tests;
- Have any known active ocular disease and/or infection;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
- Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
- Have undergone refractive error surgery;
- Are a member of the Centre for Ocular Research & Education (CORE) directly involved in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dailies Total1 Multifocal, ACUVUE OASYS MAX 1-Day Multifocal
Fit participant with Dailies Total1 Multifocal first, and with ACUVUE OASYS MAX 1-Day Multifocal second.
|
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia.
Other Names:
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia
Other Names:
|
|
Experimental: ACUVUE OASYS MAX 1-Day Multifocal, Dailies Total1 Multifocal
Fit participant with ACUVUE OASYS MAX 1-Day Multifocal first, and with Dailies Total1 Multifocal second.
|
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia.
Other Names:
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
High contrast visual acuity (logMAR) at 6m
Time Frame: Day 1
|
High contrast visual acuity (logMAR) for the dominant eye under photopic illumination at 6m
|
Day 1
|
|
High contrast visual acuity (logMAR) at 40cm
Time Frame: Day 1
|
High contrast visual acuity (logMAR) for the dominant eye under photopic illumination at 40cm
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lyndon Jones, PhD, FCOptom, Centre for Ocular Research & Education (CORE)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 25, 2024
Primary Completion (Actual)
November 21, 2024
Study Completion (Actual)
November 21, 2024
Study Registration Dates
First Submitted
April 12, 2024
First Submitted That Met QC Criteria
April 12, 2024
First Posted (Actual)
April 17, 2024
Study Record Updates
Last Update Posted (Estimated)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 4, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 46238
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
Clinical Trials on Deleficon A (multifocal)
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
CooperVision, Inc.Completed
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited States, Canada
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon, a Novartis CompanyCompletedRefractive ErrorUnited States
-
Alcon ResearchCompletedRefractive Error | PresbyopiaJapan
-
Johnson & Johnson Vision Care, Inc.Completed